Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Advanced Drug Delivery Reviews
|
November 24, 2001
Chitosan for mucosal vaccination
I M van der Lubben, J C Verhoef, G Borchard, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 29, 2001
Chitosan and its derivatives in mucosal drug and vaccine delivery
I M van der Lubben, J C Verhoef, G Borchard, et al.
Antiviral Research
|
July 14, 2009
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008
M Jonges, I M van der Lubben, F Dijkstra, et al.
Journal of Drug Targeting
|
May 30, 2001
In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry
I M Van Der Lubben, F A Konings, G Borchard, et al.
Biomaterials
|
March 15, 2001
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches
I M van der Lubben, J C Verhoef, A C van Aelst, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
October 28, 2017
[Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions]
T Leenstra, T Bosch, A L Vlek, et al.
Journal of Drug Targeting
|
February 11, 2003
Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model
I M van der Lubben, F A C van Opdorp, M R Hengeveld, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 30, 2009
[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]
Marion P G Koopmans, Adam Meijer, Mariken I M van der Lubben, et al.
The Netherlands Journal of Medicine
|
October 16, 2013
The aetiology of community-acquired pneumonia and implications for patient management
A B van Gageldonk-Lafeber, P C Wever, I M van der Lubben, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Advanced Drug Delivery Reviews
|
November 24, 2001
Chitosan for mucosal vaccination
I M van der Lubben, J C Verhoef, G Borchard, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 29, 2001
Chitosan and its derivatives in mucosal drug and vaccine delivery
I M van der Lubben, J C Verhoef, G Borchard, et al.
Antiviral Research
|
July 14, 2009
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008
M Jonges, I M van der Lubben, F Dijkstra, et al.
Journal of Drug Targeting
|
May 30, 2001
In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry
I M Van Der Lubben, F A Konings, G Borchard, et al.
Biomaterials
|
March 15, 2001
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches
I M van der Lubben, J C Verhoef, A C van Aelst, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
October 28, 2017
[Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions]
T Leenstra, T Bosch, A L Vlek, et al.
Journal of Drug Targeting
|
February 11, 2003
Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model
I M van der Lubben, F A C van Opdorp, M R Hengeveld, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 30, 2009
[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]
Marion P G Koopmans, Adam Meijer, Mariken I M van der Lubben, et al.
The Netherlands Journal of Medicine
|
October 16, 2013
The aetiology of community-acquired pneumonia and implications for patient management
A B van Gageldonk-Lafeber, P C Wever, I M van der Lubben, et al.
Page
of 1